Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. - Wikidata - thesis-toulmin - TriplyDB

Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.

Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.

http://www.wikidata.org/entity/Q37709674

about

Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches Immunology of psoriasis KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments New Developments in Biomarkers for Atopic Dermatitis Psoriasis and Atopic Dermatitis.Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy Th2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6)Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.Therapeutic strategies in extrinsic atopic dermatitis: focus on inhibition of IL-4 as a new pharmacological approach.IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.Early-onset atopic dermatitis in children: which are the phenotypes at risk of asthma? Results from the ORCA cohort Clinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly.Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data.Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the "con" view.Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets Pathways to managing atopic dermatitis: consensus from the experts Eczema Is Associated with Childhood Speech Disorder: A Retrospective Analysis from the National Survey of Children's Health and the National Health Interview Survey.Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome.Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action.Human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis via regulation of B lymphocyte maturation.Proteases and proteomics: cutting to the core of human skin pathologies.Mast Cells Regulate Epidermal Barrier Function and the Development of Allergic Skin Inflammation.T-helper 22 cells as a new player in chronic inflammatory skin disorders.Targeting key proximal drivers of type 2 inflammation in disease.Drug evaluation review: dupilumab in atopic dermatitis.The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.Atopic dermatitis in older adults: A viewpoint from geriatric dermatology.Anti-inflammatory therapies in atopic dermatitis.A novel therapeutic paradigm for patients with extensive alopecia areata.Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update.Commonality of the IL-4/IL-13 pathway in atopic diseases.Atopic dermatitis phenotypes and the need for personalized medicine.The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis.

P2860

Q26739986-5FE099BC-D401-4120-878C-5C02B3AD9A58 Q26798373-55B1564E-2E46-4CFF-BDEC-C64574B68D92 Q26799532-EC10F38A-027A-4E19-922C-A2E22C6A7BD1 Q26852335-278D4E45-43E0-454C-A685-EDEA513D2D16 Q26995800-DF93922C-2D7A-4298-BF5B-EC3B3AAD5961 Q27310680-2B44CA00-3A0F-40EB-A510-1409EFADCC87 Q28072685-F574CC4F-6C03-450D-8E33-F786718EB759 Q28396611-B45A4039-60B2-4514-8CD9-9787064B2C1E Q30238648-9CE26CC3-44F5-477F-B71E-091501F344D0 Q33713754-4F9128DD-63BD-4F1B-96CD-C8DB09F45384 Q33916807-93424FA3-45AE-4D7D-9677-51C2A4F97881 Q34006054-F1AEA367-7A10-42D0-830A-8C0B252ED95F Q34441795-2086FC34-3E6E-487C-AC37-E6FCAD69BDE8 Q35108924-AC1777CB-6C0D-47FD-872F-D926F3B63A44 Q35532126-97B4B553-2C35-40EE-8D45-291A9C616056 Q35539472-1D6E5FEB-95AE-47C5-91E4-9F0322A6EE49 Q35673293-C1CCA6BA-FA5F-4CD0-BFF3-939BC0777A8C Q35750607-22171241-EDBC-4772-AB50-5DFBB280BBC3 Q36121354-D24A71A1-1E94-4BC7-B8F7-C51BCC374FB7 Q36378437-1E2FBCF1-AF23-44A4-BD93-A71F70E008CA Q36811137-AA028B25-AF5A-4168-9300-6C4613C46E45 Q37098142-41CFF734-C4D2-402F-A8C5-372C0A4480F9 Q37258723-B104B37E-F2E6-49C6-87F4-AC2584AC75F9 Q37562833-1965A1FE-C8A6-4D10-9DC7-4EC2D047B522 Q37630234-1235ED58-8921-427B-A109-F11A9063C22F Q37690626-1347A1F9-1506-4429-A7E8-6DDB2ED7905F Q37702303-3CCBF2D4-E314-476B-B5C6-C3823F844EA6 Q38200069-FAFC19CC-D08A-4DB2-B037-0555FBE23EE0 Q38408903-CB183EC9-C8C2-4A51-8270-C80ED42CAA21 Q38548745-8C2E00AA-1811-4E8D-8A3C-D44C8AD57BA3 Q38608260-630494C3-EA96-42B9-BBD3-3C5FBEF891D3 Q38645192-7290E914-0641-436A-A1F5-1685C9D44360 Q38733182-0F897B19-AA18-4906-B847-A58846A494C2 Q38790589-A2E48918-FCAC-4BD8-B323-47889BB3B097 Q38812100-5B068094-9B8B-4419-9AB8-F49AC74ABBC7 Q38831003-C6EC8FE9-1087-4396-B5ED-83FE839AE692 Q38883893-9639BE3F-505D-4B6C-850B-46D209963E73 Q39170851-028773FA-5236-41D6-A091-B55DD1B66B85 Q39352185-3BFDE1A3-7992-42D0-91B7-D23F685DD0F4 Q39402846-7B3C5612-88C1-466E-9ECA-2CA115F044A7

P2860

Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.

http://www.wikidata.org/entity/Q37709674

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intrinsic atopic dermatitis sh ...... h extrinsic atopic dermatitis.

@en

Intrinsic atopic dermatitis sh ...... h extrinsic atopic dermatitis.

@nl

type

label

Intrinsic atopic dermatitis sh ...... h extrinsic atopic dermatitis.

@en

Intrinsic atopic dermatitis sh ...... h extrinsic atopic dermatitis.

@nl

prefLabel

Intrinsic atopic dermatitis sh ...... h extrinsic atopic dermatitis.

@en

Intrinsic atopic dermatitis sh ...... h extrinsic atopic dermatitis.

@nl

P1433

Q37709674-85B92477-0AD1-4C5C-9DA4-07865041E9F3

P1476

Q37709674-80134C85-DCF7-4C8C-9A1B-88B5E2C3B58C

P2093

Q37709674-0E1BDCC4-7D9E-4038-8753-5CB4F7FB0BD8

Q37709674-3B0D2B1E-C7E8-4871-A8E0-11D9914B08BF

Q37709674-5F7463F5-1965-45C5-B45F-2F8B7894C6D5

Q37709674-9E5D346F-6B5A-4FC0-B08F-2A1BBB0BC396

Q37709674-BDFD77A8-8C03-43D1-8BC5-8171390CD033

Q37709674-E68537DC-FEFC-4B2D-A9A3-08F46E32CD84

Q37709674-F51AF482-A36F-4D18-BCB0-53C0E76806D7

P2860

Q37709674-00539329-3F55-4DB8-8893-BCC477AC778B

Q37709674-04B308CD-D3AE-447A-90BA-8060865F3385

Q37709674-05888E0D-EB76-48E0-8F9C-34CECC08B032

Q37709674-074A01C0-C31F-4332-856A-91A277342926

Q37709674-08198311-F0B5-4CA3-B47F-246C977DFA44

Q37709674-19514DAC-7A65-49B2-8713-363E8DCC18D4

Q37709674-1A2C0455-6423-40AA-8592-758F458D1519

Q37709674-2049A8E7-06C7-4B93-AE40-3927C5FA61BA

Q37709674-25A74C7E-3993-40C5-B754-DECFDB6C9F30

Q37709674-264DE25B-DC9A-4E75-ACB5-13C481E9BD63

P304

Q37709674-94A879B4-23BC-4A00-A53A-2BF49F8180CD

P31

Q37709674-64196E08-6F79-4DA0-836D-AB659F2B63FC

P356

Q37709674-181094CE-EE63-457F-A652-53E1EE26210D

P407

Q37709674-1ADD914E-FCB2-4299-8701-A555E38113FF

P433

Q37709674-544A4537-82DB-4870-8C01-4F628CEE2792

P478

Q37709674-2DDAEB15-6B93-4B4B-AA37-6AD0BB2C0532

P50

Q37709674-F760771C-2A7D-476B-98C2-2B6D34321DEF

P577

Q37709674-C6515617-1D3B-4774-A8D1-362DA64A85AE

P5875

Q37709674-12A0FF28-2A77-4F22-97A6-ABFE9327EE8D

P698

Q37709674-EA8468A6-D186-4026-B739-A0C878AEB7A3

P932

Q37709674-7915A9F6-2A4B-4D32-9B4B-D24DA446BB60

P356

J.JACI.2013.04.046

P1433

The Journal of Allergy and Clinical Immunology

P1476

Intrinsic atopic dermatitis sh ...... th extrinsic atopic dermatitis

@en

P2093

Avner Shemer

http://www.w3.org/2001/XMLSchema#string

Emma Guttman-Yassky

http://www.w3.org/2001/XMLSchema#string

Irma Cardinale

http://www.w3.org/2001/XMLSchema#string

James G Krueger

http://www.w3.org/2001/XMLSchema#string

Julia Gittler

http://www.w3.org/2001/XMLSchema#string

Mayte Suárez-Fariñas

http://www.w3.org/2001/XMLSchema#string

Nikhil Dhingra

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

IL-24 transgenic mice: in vivo evidence of overlapping functions for IL-20, IL-22, and IL-24 in the epidermis

Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.

IgE in asthma and atopy: cellular and molecular connections.

Induction and regulation of the IgE response.

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.

The Efficacy and Safety of Long-term Oral Cyclosporine Treatment for Patients with Atopic Dermatitis.

Recalcitrant atopic dermatitis treated with omalizumab.

P304

361-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2013.04.046

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Cristina de Guzman Strong

P577

2013-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239946842

http://www.w3.org/2001/XMLSchema#string

P698

23777851

http://www.w3.org/2001/XMLSchema#string

P932

3991240

http://www.w3.org/2001/XMLSchema#string